These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17314997)

  • 1. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.
    Barrios V; Escobar C; Calderón A; Echarri R; González-Pedel V; Ruilope LM;
    J Hum Hypertens; 2007 Jun; 21(6):479-85. PubMed ID: 17314997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of microalbuminuria in non-diabetic hypertensive patients attended by Portuguese GPs.
    Polónia J; Carmona J; Mendes E; Pisco L
    Rev Port Cardiol; 2007 Jun; 26(6):637-44. PubMed ID: 17849947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why is cardiovascular risk stratification important in hypertensive patients?
    Coll-De-Tuero G; Saez M; Rodriguez-Poncelas A; Barceló-Rado A; Vargas-Vila S; Garre-Olmo J; Sala V; Sieira A; Gelada E; Gelado-Ferrero J
    Blood Press; 2012 Jun; 21(3):182-90. PubMed ID: 22486493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and management of patients with chronic ischemic heart disease according to age in the population daily attended by cardiologists in Spain The ELDERCIC study.
    Barrios V; Escobar C; Murga N; Quijano JJ
    Eur J Intern Med; 2010 Jun; 21(3):180-4. PubMed ID: 20493419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
    Cuspidi C; Meani S; Valerio C; Sala C; Fusi V; Zanchetti A; Mancia G
    Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse pressure and the metabolic syndrome in patients with hypertension.
    Barrios V; Escobar C; Echarri R; Matalí A
    J Cardiometab Syndr; 2009; 4(2):72-5. PubMed ID: 19614792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factors of cardiovascular risk for hypertensive patients followed during primary care].
    Ben Abdelaziz A; Elrafei W; Gaha K; Mandhouj O; Ben Othman A; Ghannem H
    Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk and blood pressure control in a Spanish hypertensive population attended in a Primary Care setting. Data from the PRESCAP 2006 study.
    Rodriguez-Roca GC; Llisterri-Caro JL; Barrios-Alonso V; Alonso-Moreno FJ; Lou-Arnal S; Prieto-Diaz MA; Sanchez-Ruiz T; Dura-Belinchon R; Santos-Rodriguez JA; Divison-Garrote JA; Gonzalez-Segura D; Banegas-Banegas JR; ;
    Blood Press; 2009; 18(3):117-25. PubMed ID: 19455457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
    Navarro J; Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Bonet A; González-Esteban J
    Blood Press; 2007; 16(1):20-7. PubMed ID: 17453748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of optic fundus examination with retinography in initial evaluation of hypertensive patients.
    Foguet Q; Rodríguez A; Saez M; Ubieto A; Beltrán M; Barceló MA; Coll G;
    Am J Hypertens; 2008 Apr; 21(4):400-5. PubMed ID: 18369359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proportion of isolated clinical hypertension in primary care settings. Comparison of target organ damage in patients with isolated clinical hypertension and patients with sustained arterial hypertension.
    Boreu QF; de Tuero GC; Rodríguez-Poncelas A; Albertos MS; Zafra MS; Radó MA;
    Blood Press; 2007; 16(6):354-61. PubMed ID: 17852096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study.
    Rossignol P; Hosseini K; Tropeano AI; Fay R; Tsatsaris A; Guillemin F; Mounier-Vehier C
    J Hypertens; 2013 Jan; 31(1):177-85. PubMed ID: 23111625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk assessment in hypertensive patients with tests recommended by the European Guidelines on Hypertension.
    Gómez-Marcos MA; González-Elena LJ; Recio-Rodríguez JI; Rodríguez-Sánchez E; Magallón-Botaya R; Muñoz-Moreno MF; Patino-Alonso MC; García-Ortiz L
    Eur J Prev Cardiol; 2012 Jun; 19(3):515-22. PubMed ID: 21450575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk profile of young hypertensive patients: the OPENJOVEN study.
    Martell-Claros N; Galgo-Nafria A;
    Eur J Prev Cardiol; 2012 Jun; 19(3):534-40. PubMed ID: 21474438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.